FDA inspection
Intercept Pharmaceuticals, Inc.: FDA inspection ending Apr 22, 2024
FDA inspection 1236571 · Voluntary Action Indicated (VAI) · Morristown, NJ
Key facts
| Inspection ID | 1236571 |
|---|---|
| Firm | Intercept Pharmaceuticals, Inc. |
| FEI number | 3022318150 |
| Address | 305 Madison Ave |
| City | Morristown |
| State | NJ |
| ZIP | 07960 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Apr 22, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data